Identification of the heparin-binding domain of TNF-alpha and its use for efficient TNF-alpha purification by heparin-Sepharose affinity chromatography

被引:20
作者
Kenig, Maja [1 ]
Gaberc-Porekar, Vladka [2 ]
Fonda, Irena [2 ]
Menart, Viktor [1 ,2 ]
机构
[1] Lek Pharmaceut Dd, SL-1526 Ljubljana, Slovenia
[2] Natl Inst Chem, SL-1001 Ljubljana, Slovenia
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2008年 / 867卷 / 01期
关键词
heparin-binding domain; TNF-alpha; affinity chromatography;
D O I
10.1016/j.jchromb.2008.03.023
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The N-terminus of the trimeric TNF-alpha molecule comprises two basic arginines within the short amino-acid sequence VRSSSR, which is here shown to be essential for binding of TNF-alpha to heparin-Sepharose. Mixed trimers containing full-length and Delta N6-truncated subunits revealed a single VRSSSR sequence to be sufficient to achieve binding. On the basis of this newly identified heparin-binding domain, a new method for efficient purification of TNF-alpha is described. Affinity chromatography on heparin-Sepharose was introduced as a key step for highly purified TNF-alpha at a high yield. With minor modifications, this procedure can be used for TNF-alpha analogues that have full-length N-termini, as shown for the less toxic analogue LK-805. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 36 条
[1]  
ADAMS B, 1987, LYMPHOKINE RES, V6, P203
[2]  
AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
[3]   A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma:: Implication for immunotherapy of human hepatocellular carcinoma [J].
Atarashi, Y ;
Yasumura, S ;
Nambu, S ;
Yoshio, Y ;
Murakami, J ;
Takahara, T ;
Higuchi, K ;
Watanabe, A ;
Miyata, K ;
Kato, M .
HEPATOLOGY, 1998, 28 (01) :57-67
[4]   DISSOCIATION OF TNF-ALPHA CYTOTOXIC AND PROINFLAMMATORY ACTIVITIES BY P55 RECEPTOR-SELECTIVE AND P75 RECEPTOR-SELECTIVE TNF-ALPHA MUTANTS [J].
BARBARA, JAJ ;
SMITH, WB ;
GAMBLE, JR ;
VANOSTADE, X ;
VANDENABEELE, P ;
TAVERNIER, J ;
FIERS, W ;
VADAS, MA ;
LOPEZ, AF .
EMBO JOURNAL, 1994, 13 (04) :843-850
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   MOLECULAR MODELING OF PROTEIN-GLYCOSAMINOGLYCAN INTERACTIONS [J].
CARDIN, AD ;
WEINTRAUB, HJR .
ARTERIOSCLEROSIS, 1989, 9 (01) :21-32
[7]  
*CFPMP EUR AG EV M, 1999, EUR PUBL ASS REP
[8]   Identification of a major heparin-binding site in kallistatin [J].
Chen, VC ;
Chao, L ;
Pimenta, DC ;
Bledsoe, G ;
Juliano, L ;
Chao, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1276-1284
[9]   STRUCTURE OF HUMAN-TUMOR NECROSIS FACTOR-ALPHA DERIVED FROM RECOMBINANT-DNA [J].
DAVIS, JM ;
NARACHI, MA ;
ALTON, NK ;
ARAKAWA, T .
BIOCHEMISTRY, 1987, 26 (05) :1322-1326
[10]  
De Wilt JHW, 2000, ANTICANCER RES, V20, P3491